Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"

NCT03209518 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03209518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03209518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
March 18, 2016
Completion date
October 10, 2018
Enrollment
312 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premenopausal breast cancer